Sensei Biotherapeutics Announces New Clinical Data from the Ongoing Phase 1/2 Combination Trial of SNS-301 in Patients with Squamous Cell Carcinoma of the Head and Neck

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement